NeuroHELP

Portable Neurotechnology for Forecasting Epileptic Seizures

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in January 2018 by Nadav Karni, Oren Shriki, Hadar Ron, and Shay Ben Sasson, NeuroHELP operates with 11–50 employees. The company is currently in the Pre-Funding stage, focusing on developing advanced neurotechnology. In September 2020, researchers at Ben-Gurion University developed a device that predicts epileptic seizures, aligning with NeuroHELP's core mission.

Business overview

NeuroHELP is developing a portable EEG system designed for daily use by epilepsy patients. This system utilizes advanced algorithms for signal preprocessing, artifact removal, and machine learning to analyze brain activity and predict impending seizures. The technology aims to improve the quality of life for individuals with epilepsy by providing advance alerts, reducing anxiety, and assisting in optimizing drug regimens. NeuroHELP operates within the Health Tech & Life Sciences sector, specifically focusing on medical devices and neurology, serving healthcare providers.

Strategic signal

In September 2020, researchers at Ben-Gurion University developed a device capable of predicting epileptic seizures. This development is highly significant for NeuroHELP, as it validates the core technological approach and market need for their portable EEG system. For investors, this signals strong academic and research backing for the underlying science, suggesting a robust foundation for NeuroHELP's product development and potential for market adoption in the neurotechnology space.

Log in to access full profile

Company Intelligence Q&A

When was NeuroHELP founded and by whom?
NeuroHELP was founded in January 2018 by Nadav Karni, Oren Shriki, Hadar Ron, and Shay Ben Sasson.
What is NeuroHELP's primary focus?
NeuroHELP focuses on developing a portable EEG system for epilepsy patients to forecast seizures, improve quality of life, and optimize treatment.
What is the current employee size of NeuroHELP?
NeuroHELP currently has 11–50 employees.
What is the significance of the research from Ben-Gurion University in September 2020?
In September 2020, researchers at Ben-Gurion University developed a device that predicts epileptic seizures, which aligns with NeuroHELP's mission and technological approach.
What technology underpins NeuroHELP's seizure prediction system?
NeuroHELP's system uses algorithmic solutions for signal preprocessing, artifact removal, advanced nonlinear measures of brain activity, and machine learning techniques to integrate information and assess seizure likelihood.
Log in to access full profile